Headquartered in Lexington, MA, iSpecimen is the marketplace for human biospecimens, providing researchers with the specimens they need from the patients they want. The privately held company has developed the iSpecimen Marketplace, an online platform connecting healthcare organizations that have access to patients and specimens with the scientists who need them. Proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. Researchers easily and compliantly gain access to specimens to drive scientific discovery. Partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. And ultimately, healthcare advances for all.
Location: United States, Massachusetts, Lexington
Employees: 51-200
Phone: +1 781-301-6700
Total raised: $9M
Founded date: 2009
Investors 1
| Date | Name | Website |
| - | MassChalle... | masschalle... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 26.09.2024 | - | $1M | - |
| 04.09.2014 | Series B | $8M | - |
Mentions in press and media 22
| Date | Title | Description |
| 26.09.2024 | iSpecimen Secures $1 Million Loan; Appoints Three New Board Members | WOBURN, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare s... |
| 12.03.2024 | iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call | The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern LEXINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (... |
| 12.03.2024 | iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call | - |
| 05.03.2024 | iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024 | - |
| 23.01.2024 | iSpecimen and TriMetis Life Sciences Forge Strategic Partnership for Advancing Tissue-Based Research | iSpecimen Inc. an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it entered into a pilot program agreement with TriMetis L... |
| 23.01.2024 | iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research | Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Services iSpecimen Inc. (NASDAQ:ISPC)LEXINGTON, MASSACHUSETTS, UNITED STATES, January 23, 2024 /EINPresswire.com/ -- iSpecimen Inc. (Nasdaq: ISPC) ... |
| 14.01.2022 | iSpecimen Expands COVID-19 Research with Sequences Specimens to Detect Variants | What You Should Know: – iSpecimen, the developer of an online marketplace that connects human biospecimen with researchers, announced that is has expanded its supplier capabilities in support of COVID-19 researchers. – Through a new partner... |
| 29.11.2021 | ISpecimen Inc. Announces $21 Million Private Placement | iSpecimen Inc. an online marketplace for human biospecimens, announced that it has entered into a definitive securities purchase agreement for a private placement with three accredited investors for the sale of 1,749,999 shares of common st... |
| 18.08.2021 | iSpecimen Expands Human Biospecimen Offerings for Cancer Researchers | |
| 29.07.2021 | iSpecimen Launches Enhanced Custom Collection Service |
Show more